These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30684157)

  • 21. Mapping of genetic deletions on chromosome 3 in colorectal cancer: loss of 3p25-pter is associated with distant metastasis and poor survival.
    Tsai MH; Fang WH; Lin SH; Tzeng ST; Huang CS; Yen SJ; Chou SJ; Yang YC
    Ann Surg Oncol; 2011 Sep; 18(9):2662-70. PubMed ID: 21347784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
    Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study.
    Samawi HH; Yin Y; Speers CH; Cheung WY
    Clin Colorectal Cancer; 2018 Dec; 17(4):e711-e717. PubMed ID: 30120076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
    Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
    Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
    Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
    Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter Study.
    Hishida T; Tsuboi M; Okumura T; Boku N; Ohde Y; Sakao Y; Yoshiya K; Hyodo I; Mori K; Kondo H
    Ann Thorac Surg; 2017 Feb; 103(2):399-405. PubMed ID: 27793399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification.
    Weigl K; Hsu L; Knebel P; Hoffmeister M; Timofeeva M; Farrington S; Dunlop M; Brenner H
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00106. PubMed ID: 31800541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
    Chen KH; Shao YY; Chen HM; Lin YL; Lin ZZ; Lai MS; Cheng AL; Yeh KH
    BMC Cancer; 2016 May; 16():327. PubMed ID: 27221731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
    Weigl K; Jansen L; Chang-Claude J; Knebel P; Hoffmeister M; Brenner H
    Int J Cancer; 2016 Nov; 139(10):2213-20. PubMed ID: 27459311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of family history and survival in patients with colorectal cancer: a pooled analysis of eight epidemiologic studies.
    Chong DQ; Banbury BL; Phipps AI; Hua X; Kocarnik J; Peters U; Berndt SI; Huang WY; Potter JD; Slattery ML; White E; Campbell PT; Harrison T; Newcomb PA; Chan AT
    Cancer Med; 2018 May; 7(5):2192-2199. PubMed ID: 29582567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal cancer prognosis among patients with inflammatory bowel disease.
    Delaunoit T; Limburg PJ; Goldberg RM; Lymp JF; Loftus EV
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):335-42. PubMed ID: 16527697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic outcome and recurrence rate following anastomotic leakage after curative resection for colorectal cancer.
    Ramphal W; Boeding JRE; Gobardhan PD; Rutten HJT; de Winter LJMB; Crolla RMPH; Schreinemakers JMJ
    Surg Oncol; 2018 Dec; 27(4):730-736. PubMed ID: 30449500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
    Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ
    Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer.
    Birgisson H; Ghanipour A; Smedh K; Påhlman L; Glimelius B
    Fam Cancer; 2009; 8(4):555-61. PubMed ID: 19714489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.